We wrote last month on litigation involving Pfizer’s blockbuster cholesterol treatment Lipitor. A lawsuit has been filed against Pfizer by a Louisiana woman, alleging that she developed Type 2 diabetes after taking Lipitor for roughly a decade starting in the late 1990s. It was alleged that Pfizer fraudulently hid Lipitor’s potential link to blood sugar levels until 2012. Gladys Board claimed in her suit, filed in Louisiana federal court, that Pfizer had not included a warning about increased glucose levels associated with Lipitor until after the U.S. Food and Drug Administration (FDA) requested that it do so in 2011, based on its review of the drug.
It was alleged in the suit that the warning does not sufficiently warn consumers about the “serious” risk of developing diabetes by taking the drug, Ms. Board claimed that Pfizer and its predecessors have had data at least since 1996 that suggested a link between Lipitor and Type 2 diabetes.
Source: Law360.com
